The young Rothamsted scientists walked away with prizes including £1,000 after impressing judges at the final of Biotechnology YES with their hypothetical business plan for a company called Phytofend and its revolutionary product called SlugFast, a genetically modified Hosta plant proven to be a highly effective means of slug control. Hosta is naturally attractive to slugs and the SlugFast variety has been transformed to express a novel appetite suppressing protein, the plant attracts slugs and, upon ingestion, causes them to stop feeding.
Biotechnology Young Entrepreneurs Scheme (YES) is an annual competition organised by the Biotechnology and Biological Sciences Research Council (BBSRC) and the University of Nottingham Institute for Enterprise and Innovation (UNIEI). It helps young researchers understand how to set up their own biotech company by developing business awareness and the skills needed to be successful entrepreneurs. This year 51 teams of 248 individuals were whittled down to 8 teams in the final through a series of regional heats where they were able to draw on advice from mentors with experience in enterprise, innovation, patent law and equity investment. Other prizes scooped by the Rothamsted Research scientists for their win include sponsored places at the BioIndustry Association Dinner and the opportunity, provided by the UK Trade and Industry, to give a presentation at a prestigious US business plan competition at Rice University in Texas.
Dr Peter Ringrose, Chairman of BBSRC and head of the judging panel, said: " The Rothamsted Research team showed an excellent grasp of the principles of finance, marketing and intellectual property rights needed to be a success should they ever decide to enter the world of commercial biotech. Biotechnology YES has been running for over a decade and the quality of entries continues to climb. Together with the rest of the judging panel I have been hugely impressed by all of this year's finalists and the careful preparation that clearly went into every team's business plan."
Stephen Pearce, who took the role of Managing Director for Phytofend, said:" We are happy and surprised to win. We have learned a lot about working together and how to actually launch a spin-out company. We really didn't know anything before we started on YES but with the help of the mentors we have really learned a lot. We have enjoyed the unique opportunity as its completely different from anything else we would do in out PhDs."
"We would like to thank Gerard Bencen at PBL and Tina Crombie, James Logan and Sarah Dewhirst at Rothamsted Research for their support."
For the first time the final of Biotechnology YES saw a presentation from a team of young scientists representing the environmental sciences. Environment YES, supported by the Natural Environment Research Council (NERC) is a spin-out from the main competition. The competition was won by a team from Cranfield University with their hypothetical company Green Switch. Their product harnessed scientific breakthroughs to efficiently convert farmyard waste efficiently into electricity.
Ms Poppy Leeder, who manages the Knowledge Transfer Funding Scheme for NERC, said:" This is a really good opportunity to start training scientists in entrepreneurial awareness. I'm very pleased that this year we have been able to open up the competition for environmental scientists to take part."
Profiles for all the hypothetical companies are listed in the Notes to Editors.
Category prizes were awarded to:
- Best consideration of IP strategy sponsored by Eric Potter Clarkson - Phytofend, Rothamsted Research
- Best healthcare business plan sponsored by GlaxoSmithKline - Aptinostics, Imperial College London
- Best medical technology by Smith & Nephew Prize - Nanozorb, University of Manchester
- Best plant science business plan sponsored by Syngenta - Phytofend, Rothamsted Research
- Best presenter sponsored by Tim Hart, Cybersense BioSystems - Leila Shepherd, Aptinostics, Imperial College London
- Pfizer Prize for Innovation - CereAll, Institute for Animal Health
Dr Mark Edwards, Senior Director of Science Policy, Global Research & Development at Pfizer, which sponsored the prize for Innovation, said: "Biotechnology YES showcases the next generation of scientists who are going to preserve the future of clinical and academic R&D in the UK. Success in business requires an understanding of the complete package that includes innovation, intellectual property and the workings of the market and YES gives this to participants."
ContactMatt Goode, Head of Media, BBSRC
Press Office | alfa
Embryonic development: How do limbs develop from cells?
18.05.2018 | Humboldt-Universität zu Berlin
Reading histone modifications, an oncoprotein is modified in return
18.05.2018 | American Society for Biochemistry and Molecular Biology
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...
A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.
The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...
Cardiovascular tissue engineering aims to treat heart disease with prostheses that grow and regenerate. Now, researchers from the University of Zurich, the Technical University Eindhoven and the Charité Berlin have successfully implanted regenerative heart valves, designed with the aid of computer simulations, into sheep for the first time.
Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing...
A team of scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg investigated optically-induced superconductivity in the alkali-doped fulleride K3C60under high external pressures. This study allowed, on one hand, to uniquely assess the nature of the transient state as a superconducting phase. In addition, it unveiled the possibility to induce superconductivity in K3C60 at temperatures far above the -170 degrees Celsius hypothesized previously, and rather all the way to room temperature. The paper by Cantaluppi et al has been published in Nature Physics.
Unlike ordinary metals, superconductors have the unique capability of transporting electrical currents without any loss. Nowadays, their technological...
02.05.2018 | Event News
13.04.2018 | Event News
12.04.2018 | Event News
18.05.2018 | Power and Electrical Engineering
18.05.2018 | Information Technology
18.05.2018 | Information Technology